Manatt Health February 2, 2022
Despite the unprecedented challenges of the COVID-19 pandemic, mergers and acquisitions in the health care industry have continued apace and show no signs of slowing. According to a recent PricewaterhouseCoopers report, these types of transactions surged by 56% in the 12-month period ending November 15, 2021, as compared to 2020, with particularly high growth among physician medical groups. Amidst all this activity, the government’s False Claims Act (FCA) enforcement efforts are starting to focus with increasing regularity not only on private equity-owned health care companies, but also on private equity investors themselves. In fact, 2021 saw multiple developments that are likely to give the Department of Justice (DOJ) and whistleblowers the impetus for FCA lawsuits targeting private equity firms.
For...
Today's Sponsors
Today's Sponsor